Patents by Inventor Scott Douglas Bergmann

Scott Douglas Bergmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230305005
    Abstract: The present specification provides reagents and methods for a rapid detection of SARS-CoV-2. The assay can be implemented in a point-of-care or laboratory setting.
    Type: Application
    Filed: August 16, 2021
    Publication date: September 28, 2023
    Inventors: Joshua Caine Soldo, Scott Douglas Bergmann
  • Publication number: 20230091170
    Abstract: The present invention is directed to methods for using particles (e.g, microparticulate, nanoparticulate; magnetic, non-magnetic) comprising surfaces comprising capture moieties as described herein, to remove an interference as described herein, or enrich biomarkers, especially antibodies, prior to a diagnostic test, or to be isolated and used for prophylactic or therapeutic purposes.
    Type: Application
    Filed: April 12, 2021
    Publication date: March 23, 2023
    Inventors: Joshua Caine Soldo, Scott Douglas Bergmann, Carmen L. Wiley
  • Publication number: 20220260557
    Abstract: The present invention is directed to methods for using particles (e.g, microparticulate, nanoparticulate; magnetic, non-magnetic) comprising surfaces comprising capture moieties as described herein, to remove an interference as described herein, or enrich biomarkers, prior to a diagnostic test.
    Type: Application
    Filed: July 26, 2019
    Publication date: August 18, 2022
    Inventors: Joshua Caine Soldo, Scott Douglas Bergmann, Carmen Leah Wiley
  • Publication number: 20220252586
    Abstract: The present specification provides methods to prepare reagents and microparticulate binding surfaces with specificity to anti-streptavidin interference and anti-biotin interference. Also disclosed is how to use reagents and microparticulate binding surfaces to block, deplete or reduce the concentration of anti-streptavidin interference and anti-biotin interference in samples below the assay blocking threshold (ABT) prior to a diagnostic test.
    Type: Application
    Filed: June 25, 2020
    Publication date: August 11, 2022
    Inventors: Joshua Caine Soldo, Scott Douglas Bergmann, Eric Nelson
  • Publication number: 20210302416
    Abstract: The present invention is directed to methods for using a plurality of particles comprising surfaces each independently comprising a capture moiety to isolate and characterize biomarkers (e.g., for obstructive sleep apnea).
    Type: Application
    Filed: July 26, 2019
    Publication date: September 30, 2021
    Inventors: Joshua Caine Soldo, Scott Douglas Bergmann, Carmen Leah Wiley
  • Publication number: 20210190768
    Abstract: The present invention is directed to methods for using particles (e.g, microparticulate, nanoparticulate; magnetic, non-magnetic) comprising surfaces comprising capture moieties as described herein, to remove an interference as described herein, or enrich biomarkers, prior to a diagnostic test.
    Type: Application
    Filed: January 27, 2021
    Publication date: June 24, 2021
    Inventors: Joshua Caine Soldo, Scott Douglas Bergmann, Carmen Leah Wiley